Schobel Alexander Mark

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$114,856.16
Insider Sells Quantity
9
Insider Sells Sum
$2.32M

Insider Activity of Schobel Alexander Mark

According to the SEC Form 4 filings, Schobel Alexander Mark, being in a position of

  1. Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 75000 shares for $429,685,
    over all time since 2018-11-21, has bought 53871 share for $114,856, and sold 470792 shares for $2.32M.

The largest purchase of all time was on 2022-06-08 and amounted to 45871 share of Aquestive Therapeutics, Inc. for $44,036.

The largest sale of all time was on 2020-05-08 and amounted to 80000 shares of Aquestive Therapeutics, Inc. for $400,000.

Biography of Schobel Alexander Mark

No biography is available at this moment.

2024-03-15SaleAquestive Therapeutics, Inc.
AQST
Chief Innovation/Tech Officer
50,000
0.0672%
$6.00$300,000-33.17%
2024-03-08SaleAquestive Therapeutics, Inc.
AQST
Chief Innovation/Tech Officer
25,000
0.0364%
$5.19$129,685-16.09%
2022-06-08PurchaseAquestive Therapeutics, Inc.
AQST
Chief Innovation/Tech Officer
45,871
0.1074%
$0.96$44,036+2.88%
2021-02-10SaleAquestive Therapeutics, Inc.
AQST
23,460
0.0662%
$6.75$158,355-38.78%
2021-02-09SaleAquestive Therapeutics, Inc.
AQST
11,540
0.0328%
$6.75$77,895-38.02%
2021-02-08SaleAquestive Therapeutics, Inc.
AQST
40,792
0.1131%
$6.50$265,148-37.03%
2020-05-08SaleAquestive Therapeutics, Inc.
AQST
80,000
0.2312%
$5.00$400,000+3.69%
2020-04-29SaleAquestive Therapeutics, Inc.
AQST
80,000
0.2256%
$4.50$360,000+12.42%
2020-04-27SaleAquestive Therapeutics, Inc.
AQST
80,000
0.229%
$4.00$320,000+28.37%
2020-04-14SaleAquestive Therapeutics, Inc.
AQST
80,000
0.2445%
$3.85$308,000+42.4%
2018-12-10PurchaseAquestive Therapeutics, Inc.
AQST
2,000
0.009%
$7.78$15,560-37.05%
2018-12-06PurchaseAquestive Therapeutics, Inc.
AQST
4,000
0.0192%
$8.69$34,760-40.29%
2018-11-21PurchaseAquestive Therapeutics, Inc.
AQST
2,000
0.0097%
$10.25$20,500-48.92%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.